Published in Cancer Res on January 01, 2010
A new tumor-specific variant of GRP78 as target for antibody-based therapy. Lab Invest (2008) 1.42
Natural IgM antibodies and immunosurveillance mechanisms against epithelial cancer cells in humans. Cancer Res (2003) 1.15
Natural antibodies and cancer. J Autoimmun (2007) 1.13
Natural antibodies and cancer. N Biotechnol (2009) 1.12
Lipoptosis: tumor-specific cell death by antibody-induced intracellular lipid accumulation. Cancer Res (2004) 1.07
High level expression of functional human IgMs in human PER.C6 cells. MAbs (2009) 1.02
The human IgM antibody SAM-6 induces tumor-specific apoptosis with oxidized low-density lipoprotein. Mol Cancer Ther (2007) 1.01
Natural IgM antibodies: the orphaned molecules in immune surveillance. Adv Drug Deliv Rev (2006) 1.01
The natural human IgM antibody PAT-SM6 induces apoptosis in primary human multiple myeloma cells by targeting heat shock protein GRP78. PLoS One (2013) 0.98
Expression and glycoengineering of functionally active heteromultimeric IgM in plants. Proc Natl Acad Sci U S A (2014) 0.93
Human monoclonal IgM antibodies with apoptotic activity isolated from cancer patients. Hum Antibodies (2002) 0.89
Early development of PAT-SM6 for the treatment of melanoma. Melanoma Res (2013) 0.88
Downregulation of CXCR1 and CXCR2 expression on human neutrophils by Helicobacter pylori: a new pathomechanism in H. pylori infection? Infect Immun (2004) 0.87
Human antibody SC-1 reduces disseminated tumor cells in nude mice with human gastric cancer. Oncol Rep (2005) 0.83
Tumors: too sweet to remember? Mol Cancer (2007) 0.83
Noninvasive visualization of tumor growth in a human colorectal liver metastases xenograft model using bioluminescence in vivo imaging. J Surg Res (2013) 0.81
The anti-cancer IgM monoclonal antibody PAT-SM6 binds with high avidity to the unfolded protein response regulator GRP78. PLoS One (2012) 0.81
Neoadjuvant therapy of gastric cancer with the human monoclonal IgM antibody SC-1: impact on the immune system. Oncol Rep (2008) 0.80
Natural human immunoglobulins in cancer immunotherapy. Immunotherapy (2009) 0.80
Cysteine-rich fibroblast growth factor receptor 1, a new marker for precancerous epithelial lesions defined by the human monoclonal antibody PAM-1. Cancer Res (2003) 0.79
PAM-1, a natural human IgM antibody as new tool for detection of breast and prostate precursors. Hum Antibodies (2004) 0.77
Nature's best weapons to fight cancer. Revival of human monoclonal IgM antibodies. Hum Antibodies (2002) 0.76
Simultaneous binding of the anti-cancer IgM monoclonal antibody PAT-SM6 to low density lipoproteins and GRP78. PLoS One (2013) 0.76
Natural monoclonal antibodies and cancer. Recent Pat Anticancer Drug Discov (2008) 0.76
Chromatographic behavior of IgM:DNA complexes. J Chromatogr A (2010) 0.75